COPD: implementing biomarkers to improve prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021
Monitoring asthma - state-of-the-art physiological, imaging and biomarker assessments Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018
COPD prediction by using imaging and genetic profiles Source: International Congress 2014 – Pathways to personalised medicine in obstructive lung disease Year: 2014
Monitoring asthma: state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016
Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015
Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD? Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017
Comparison of different staging methods for COPD in predicting outcomes Source: Eur Respir J, 51 (3) 1700577; 10.1183/13993003.00577-2017 Year: 2018
Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018
Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Source: Eur Respir J 2016; 48: 1271-1273 Year: 2016
How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …? Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets? Year: 2019
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012
A competence framework to support the development of the workforce to deliver improved outcomes for patients with COPD and asthma Source: Annual Congress 2012 - Professional development and advanced practice roles in respiratory nursing Year: 2012
Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Are T2 biomarkers of any help in diagnosing asthma? Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
Correlations between functional performance, health status and inflammatory biomarkers in stable COPD Source: International Congress 2017 – Techniques to treat asthma Year: 2017
The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm Source: Eur Respir J, 59 (2) 2102669; 10.1183/13993003.02669-2021 Year: 2022